| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Bruker (NASDAQ:BRKR) lowers FY2025 Adj EPS guidance from $1.95-$2.05 to $1.85-$1.90 vs $1.96 analyst estimate. Lowers FY2025 sa...
Bruker (NASDAQ:BRKR) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.34 by 34.33...
Bruker Corporation (NASDAQ:BRKR) today announced new orders for advanced Nuclear Magnetic Resonance (NMR) instrumentation from ...